XODO, Luigi
 Distribuzione geografica
Continente #
NA - Nord America 7.000
EU - Europa 2.083
AS - Asia 1.404
SA - Sud America 167
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 10.675
Nazione #
US - Stati Uniti d'America 6.939
SG - Singapore 725
UA - Ucraina 618
IT - Italia 359
CN - Cina 344
DE - Germania 303
FI - Finlandia 246
RU - Federazione Russa 160
BR - Brasile 151
IE - Irlanda 108
SE - Svezia 105
TR - Turchia 78
GB - Regno Unito 68
KR - Corea 61
IN - India 56
CA - Canada 54
HK - Hong Kong 32
VN - Vietnam 30
BE - Belgio 27
JP - Giappone 27
PL - Polonia 18
FR - Francia 17
AT - Austria 14
IR - Iran 13
NL - Olanda 8
CZ - Repubblica Ceca 7
EU - Europa 7
IL - Israele 5
ID - Indonesia 4
KG - Kirghizistan 4
MX - Messico 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
AZ - Azerbaigian 3
CO - Colombia 3
EC - Ecuador 3
ES - Italia 3
LT - Lituania 3
MA - Marocco 3
PH - Filippine 3
PT - Portogallo 3
TW - Taiwan 3
ZA - Sudafrica 3
AR - Argentina 2
AU - Australia 2
CH - Svizzera 2
CL - Cile 2
HR - Croazia 2
JO - Giordania 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
PK - Pakistan 2
RS - Serbia 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
IS - Islanda 1
MD - Moldavia 1
ME - Montenegro 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
PY - Paraguay 1
TG - Togo 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 10.675
Città #
Woodbridge 871
Fairfield 813
Ann Arbor 719
Houston 522
Chandler 449
Singapore 448
Jacksonville 430
Ashburn 404
Seattle 341
Wilmington 318
Dearborn 303
Cambridge 286
Udine 156
Beijing 145
Boardman 138
Princeton 109
Dublin 107
Izmir 72
San Diego 54
Seoul 48
Helsinki 44
Ottawa 33
Hong Kong 30
Hefei 29
Ogden 29
Dong Ket 28
Brussels 27
Des Moines 27
New York 26
Los Angeles 25
Kunming 17
Norwalk 14
São Paulo 14
Baltimore 13
Falkenstein 13
Guangzhou 13
Nanjing 13
Redmond 12
Rome 12
Milan 11
Shanghai 11
Toronto 11
Vienna 11
Washington 11
Belluno 10
Düsseldorf 10
Jinan 10
Poznan 10
Santa Clara 10
Tokyo 10
Trieste 10
Birmingham 9
Brooklyn 9
Dallas 9
Frankfurt am Main 9
Nanchang 9
Ardabil 8
Augusta 8
Bologna 8
Fuzhou 8
Rivalta 8
San Mateo 8
Belo Horizonte 7
Cincinnati 7
Padova 7
Redwood City 7
Rockville 7
Turku 7
Vancouver 7
Chennai 6
London 6
Munich 6
Philadelphia 6
Shenyang 6
Warsaw 6
Nuremberg 5
Stockholm 5
Baotou 4
Bishkek 4
Brasília 4
Brno 4
Clifton 4
Hangzhou 4
Harbin 4
Indiana 4
Indianapolis 4
Leawood 4
Mumbai 4
Portsmouth 4
Rende 4
Richmond 4
San Francisco 4
Sheffield 4
Verona 4
Atlanta 3
Baku 3
Bucaramanga 3
Campinas 3
Chongqing 3
Codroipo 3
Totale 7.551
Nome #
Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites 239
Anticancer activity of cationic porphyrins in melanoma tumour-bearing mice and mechanistic in vitro studies 199
Antisense locked nucleic acids efficiently suppress BCR/ABL and induce cell growth decline and apoptosis in leukemic cells 174
Effect of cations on purine-purine-pyrimidine triple helix formation in mixed-valence salt solutions 172
THE CHLOROPHYLL CATABOLITE PHEOPHORBIDE A AS A PHOTOSENSITIZER FOR THE PHOTODYNAMIC THERAPY 168
Repeated sub-optimal photodynamic treatments with pheophorbide a induce an epithelial mesenchymal transition in prostate cancer cells via nitric oxide 157
Editorial [ Hot Topic: Applications of the Photodynamic Therapy to Cancer,Water- and Vector-Borne Diseases (Guest Editor: Luigi E. Xodo )] 155
G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription 147
Anti-gene effect in live cells of AG motif triplex-forming oligonucleotides containing an increasing number of phosphorothioate linkages 144
Cellular uptake and binding of guanidine-modified phthalocyanines to KRAS/HRAS G-quadruplexes 139
Critical role of hnRNP A1 in activating KRAS transcription in pancreatic cancer cells: A molecular mechanism involving G4 DNA 139
Potent Apoptotic Response Induced by Chloroacetamidine Anthrathiophenediones in Bladder Cancer Cells 138
Anti-gene strategies to down-regulate gene expression in mammalian cells 136
A photodynamic bifunctional conjugate for prostate cancer: an in vitro mechanistic study 135
Lipid-modified G4-decoy oligonucleotide anchored to nanoparticles: delivery and bioactivity in pancreatic cancer cells. 134
The regulatory G4 motif of the Kirsten ras (KRAS) gene is sensitive to guanine oxidation: Implications on transcription 133
Antigene property of PNA conjugated to the nuclear localization signal peptide 132
The Role Of Nitric Oxide After Repeated Low Dose Photodynamic Treatments In Prostate Carcinoma Cells 131
G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy. 129
RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation 127
Enhanced G4-DNA binding of 5,10,15,20 (N-propyl-4-pyridyl) porphyrin (TPrPyP4): a comparative study with TMPyP4 125
G4 DNA in ras genes and its potential in cancer therapy 125
Site-directed inhibition of DNA replication by triple helix formation 123
A kinetic study of triple-helix formation at a critical R-Y sequence of the murine c-Ki-ras promoter by (A,G)- and (G,T)oligonucleotides 123
G-rich oligonucleotide inhibits the binding of a nuclear protein to the Ki-ras promoter and strongly reduces cell growth in human carcinoma pancreatic cells 122
Molecular pathways in cancer response to photodynamic therapy 121
GC-elements controlling HRAS transcription form i-motif structures unfolded by heterogeneous ribonucleoprotein particle A1 120
Secondary structure effects on the interaction of different polynucleotides with Ca2+. 119
Downregulation of c-Ki-ras promoter activity by triplex-forming oligonucleotides endogenously generated in human 293 cells 118
Interleukin 1 receptor antagonist gene variable number of tandem repeats polymorphism and cutaneous melanoma 118
Small Interfering RNA-Mediated Silencing of Glutathione-S-transferase A1 Sensitizes Hepatic Carcinoma Cells to Photodynamic Therapy with Pentaphyrins 117
Inhibition of gene expression by peptide nucleic acids in cultured cells 117
Photoactivated cationic alkyl-substituted porphyrin binding to g4-RNA in the 5'-UTR of KRAS oncogene represses translation 116
(A,G)-OLIGONUCLEOTIDES FORM EXTRAORDINARY STABLE TRIPLE HELICES WITH A CRITICAL R•Y SEQUENCE OF THE MURINE C-KI-RAS PROMOTER AND INHIBIT TRANSCRIPTION IN TRANSFECTED NIH 3T3 CELLS 116
EVIDENCE THAT PHOTOACTIVATED PHEOPHORBIDE A CAUSES IN HUMAN CANCER CELLS A PHOTODYNAMIC EFFECT INVOLVING LIPID PEROXIDATION 114
MicroRNA therapeutics: design of single-stranded miR-216b mimics to target KRAS in pancreatic cancer cells 113
Primer extension reactions as a tool to uncover folding motifs within complex G-rich sequences: analysis of the human KRAS NHE 112
Guanidino anthrathiophenediones as G-quadruplex binders: uptake, intracellular localization, and anti-Harvey-Ras gene activity in bladder cancer cells. 111
Metallation of pentaphyrin with Lu(III) dramatically increases reactive-oxygen species production and cell phototoxicity 111
Synthesis and biological evaluation of new pentaphyrin macrocycles for photodynamic therapy 108
Role of RKIP in sensitizing tumor cells to photodynamic therapy 107
Photosensitizers binding to nucleic acids as anticancer agents 106
The ROS-KRAS-Nrf2 axis in the control of the redox homeostasis and the intersection with survival-apoptosis pathways: Implications for photodynamic therapy 106
Conjugated PDT drug:photosensitizing activity not tissue distribution of PEGylated pheophorbide a 105
Pivotal role of nitric oxide (NO) induction by photodynamic therapy in tumor cells:modification of the NF-kB/Snail/RKIP survival/anti-apoptotic loop 104
Reduction of mdr1 gene amplification in human multidrug resistant LoVoDX cell line is promoted by triple helix forming oligonucleotides 104
Circular dichroism as a tool of investigation in the solution behavior of nucleic acids. 101
PNA CONJUGATED TO HIGH MOLECULAR WEIGHT POLY(ETHYLENE GLYCOL):SYNTHESIS AND PROPERTIES 101
WIDESPREAD PRESENCE IN MAMMALS AND HIGH BINDING SPECIFICITY OF A NUCLEAR PROTEIN THAT RECOGNIZES THE SINGLE STRANDED (CCCTAA)N TELOMERIC MOTIF 100
MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice 98
Nanocrystalline cellulose-fullerene: Novel conjugates 98
Formation of stable DNA triple helices within the human bcr promoter at a critical oligopurine target interrupted in the middle by two adjacent pyrimidines 97
Molecular strategies to downregulate gene expression 94
Timing of cord clamping for blood gas analysis is of paramount importance 94
GUANINE-RICH OLIGONUCLEOTIDES TARGETED TO A CRITICAL R•Y SITE LOCATED IN THE KI-RAS PROMOTER. THE EFFECT OF COMPETING SELF-STRUCTURES ON TRIPLEX FORMATION 93
Purine twisted-intercalating nucleic acids: a new class of anti-gene molecules resistant to potassium-induced aggregation 93
Effect of phosphorothioate modifications on the ability of GTn oligodeoxynucleotides to specifically recognize single-stranded DNA-binding proteins and to affect human cancer cellular growth 89
Repeated low-dose Pba/PDt treatments stimulate cell growth of prostate cancer cells 89
The PDT activity of free and pegylated pheophorbide a against an amelanotic melanoma transplanted in C57/BL6 mice. 89
Evidence for a HeLa nuclear protein that binds specfically the single stranded d(CCCTAA)n telomeric motif 89
Effect of cation on RRY triple-helices in mixed-valence salt solutions 88
Pyrimidine phosphorothioate oligonucleotides form triple-stranded helices and promote transcription inhibition 88
PROTEIN hnRNP A1 AND ITS DERIVATIVE UP1 UNFOLD QUADRUPLEX DNA IN THE HUMNA KRAS PROMOTER: IMPLICATIONS FOR TRANSCRIPTION 88
Nitric oxide-mediated activity in anti-cancer photodynamic therapy. 88
“Clicking” Porphyrins to Magnetic Nanoparticles for Photodynamic Therapy 88
Antigene effect in K562 cells of a PEG-conjugated triplex-forming oligonucleotide targeted to the bcr/abl oncogene 88
INHIBITION OF T7 RNA POLYMERASE TRANSCRIPTION BY PHOSPHATE AND PHOSPHOROTHIOATE TRIPLEX-FORMING OLIGONUCLEOTIDES TARGETED TO A R•Y SITE DOWNSTREAM FORM THE PROMOTER 86
Conjugated PDT drug: photosensitizing activity and tissue distribution of PEGylated pheophorbide a 86
PDT related heavy atom effect on [1.1.1.1.1] pentaphyrins 84
Molecular models for intrastrand DNA G-quadruplexes 83
Role of Nitric oxide to improve the photodynamic therapy in prostate cancer cells 82
Antiproliferative effect in chronic myeloid leukemia cells by antisense peptide nucleic acids 80
Targeting neighbouring poly(purine-pyrimidine) sequences located in the human bcr promoter by triplex-forming oligonucleotides 79
Folate-Decorated Amphiphilic Cyclodextrins as Cell-Targeted Nanophototherapeutics 79
EVIDENCE FOR INTRAMOLECULARLY FOLDED I-DNA STRUCTURES IN BIOLOGICALLY RELEVENT CCC-REPEAT SEQUENCES 77
siRNA Treatment directed against bcr/abl b2a2 transcript in leukemic cells 77
Transcription inhibition of oncogenic KRAS by a mutation-selective peptide nucleic acid conjugated to the PKKKRKV nuclear localization signal peptide 76
Antigene treatment direct against mutated Ki-ras with a PNA conjugated to a nuclear localisation derived peptide 75
The KRAS promoter responds to MYC-associated zinc finger and poly[ADP-ribose]polymerase 1 proteins which recognize a critical quadruplex-forming GA-element 73
Specific inhibition of bcr/abl gene expression in KYO-1 cells by antisense peptide nucleic acids 71
Efficient silencing of bcr/abl oncogene by single- and double-stranded siRNAs targeted against b2a2 transcripts 71
Photooxidation and Phototoxicity of pi-extended squaraines 71
“Synthesis and Characterization of a New Pentaphyrin Macrocycle as Potential Photosensitizer.” 69
Role of NF-kB/Snail/RKIP in the response of tumour cells to photodynamic therapy 67
PEG-PNA:preparation and evalutation of PEG-conjugated peptide nucleic acids 66
Role of poly [adp-ribose] polymerase 1 in activating the kirsten ras (Kras) gene in response to oxidative stress 65
Using cellular mechanisms to improve the efficacy of photodynamic therapy in prostate cancer cells. 61
Synthesis and Activity in photodynamic therapy of poly(ethylene clycol) conjugated pheophorbide 57
null 57
Does Delayed Cord Clamping Improve Long-Term (≥4 Months) Neurodevelopment in Term Babies? A Systematic Review and a Meta-Analysis of Randomized Clinical Trials 56
Role of RKIP in sensitizing tumor cells to photodynamic therapy (PDT) 55
Effetto della terapia fotodinamica sulla transizione epitelio-mesenchimale in cellule di carcinoma prostatico 55
HRAS is silenced by two neighboring G-quadruplexes and activated by MAZ, a zinc-finger transcription factor with DNA unfolding activity 54
Antiproliferative activity of atripelx forming oligonucleotide recognizing a Ki-ras polypurine/polypyrimidine motif correlates with protein binding 53
STRUCTURAL POLYMORPHISM WITHIN A REGULATORY ELEMENT OF HUMAN KRAS PROMOTER:FORMATIONOF G4-DNA THAT IS RECOGNIZED BY NUCLEAR PROTEINS 53
Triple helix forming oligonucleotides as sequence-specific inhibitors of DNA replication 52
IDENTIFICATION OF A NEW G-QUADRUPLEX MOTIF IN THE KRAS PROMOTER AND DESIGN OF PYRENE-MIDIOFIED G4-DECOYS WITH ANTIPROLIFERATIVE ACTIVITY IN PANCREATIC CANCER CELL 52
Photodynamic therapy (PDT)-mediated inhibition of the transcription factor Yin Yan 1 (YY1) that regulates resistance in lymphoma 51
Fetal growth at term and placental oxidative stress in a tissue micro-array model: a histological and immunohistochemistry study 49
Spectroscopy characterization of the oxidation control of the iso-pentaphyrin/pentaphyrin system 49
Totale 10.133
Categoria #
all - tutte 39.232
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.232


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020168 0 0 0 0 0 0 0 0 0 0 0 168
2020/20211.354 33 147 30 203 45 155 42 147 207 72 190 83
2021/2022871 43 104 24 43 43 45 49 54 9 142 173 142
2022/20231.049 126 93 18 128 101 257 1 81 135 11 44 54
2023/2024522 76 49 45 20 74 71 35 35 43 10 15 49
2024/20251.717 44 146 88 71 112 140 122 122 269 188 393 22
Totale 10.811